Skip to main content
. 2019 Jan 9;2(4):pky058. doi: 10.1093/jncics/pky058

Table 3.

Colorectal cancer mortality according to postdiagnosis physical activity levels in all cases or in strata of quartiles of CD3+ cell density by sex

Colorectal cancer-specific mortality HR for a quartile-unit increase of postdiagnosis physical activity levels
Overall mortality HR for a quartile-unit increase of postdiagnosis physical activity levels
Characteristic No. of cases No. of events Univariate HR (95% CI)* Multivariable HR (95% CI)* No. of events Univariate HR (95% CI)* Multivariable HR (95% CI)*
Female
 All colorectal cancer cases 252 55 0.72 (0.55 to 0.93) 0.72 (0.55 to 0.94) 134 0.68 (0.58 to 0.80) 0.68 (0.57 to 0.80)
 CD3+ cell density
  Quartile 1 (lowest) 56 15 0.49 (0.27 to 0.87) 0.45 (0.25 to 0.82) 27 0.52 (0.34 to 0.80) 0.57 (0.35 to 0.91)
  Quartile 2 61 14 0.78 (0.47 to 1.29) 0.86 (0.50 to 1.48) 30 0.56 (0.39 to 0.79) 0.55 (0.39 to 0.77)
  Quartile 3 65 15 0.90 (0.55 to 1.48) 0.74 (0.44 to 1.25) 40 0.92 (0.69 to 1.22) 0.86 (0.65 to 1.15)
  Quartile 4 (highest) 53 6 0.55 (0.38 to 0.80) 0.66 (0.44 to 1.00) 29 0.67 (0.50 to 0.91) 0.74 (0.53 to 1.02)
  Pinteraction .071 .11 .60 .37
Male
 All colorectal cancer cases 218 45 0.83 (0.65 to 1.07) 0.69 (0.50 to 0.96) 141 0.87 (0.75 to 1.01) 0.98 (0.85 to 1.13)
 CD3+ cell density
  Quartile 1 (lowest) 55 15 0.73 (0.46 to 1.15) 0.64 (0.39 to 1.05) 42 0.90 (0.70 to 1.15) 0.93 (0.74 to 1.17)
  Quartile 2 50 9 0.77 (0.43 to 1.39) 0.60 (0.32 to 1.13) 34 0.79 (0.62 to 1.01) 0.90 (0.70 to 1.15)
  Quartile 3 47 10 0.50 (0.23 to 1.09) 0.55 (0.26 to 1.20) 28 0.63 (0.41 to 0.99) 0.82 (0.53 to 1.26)
  Quartile 4 (highest) 58 9 1.58 (0.98 to 2.55) 1.55 (0.86 to 2.80) 31 1.08 (0.76 to 1.54) 1.18 (0.84 to 1.65)
  Pinteraction .001 <.001 .25 .27
*

IPW was applied to reduce a bias due to the availability of questionnaire data after cancer diagnosis (see “Statistical Analysis” subsection for details). CI = confidence interval; HR = hazard ratio; IPW = inverse probability weighting.

The multivariable IPW-adjusted Cox regression model initially included age, year of diagnosis, family history of colorectal cancer, body mass index, prediagnosis physical activity, tumor location, tumor differentiation, disease stage, microsatellite instability, CpG island methylator phenotype, long interspersed nucleotide element-1 methylation level, KRAS mutation, BRAF mutation, PIK3CA mutation, nuclear CTNNB1 (beta-catenin) expression, PTGS2 (cyclooxygenase-2) expression, and IRS1 expression. A backward elimination with a threshold of P equal to .05 was used to select variables for the final models.

P interaction was calculated using the Wald test for the cross-product of postdiagnosis physical activity levels (the median value of each decile category) and each T cell subset (the median value of each decile category) in the IPW-adjusted Cox regression model.